Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_assertion type Assertion NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_head.
- NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_assertion description "[Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_provenance.
- NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_assertion evidence source_evidence_literature NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_provenance.
- NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_assertion SIO_000772 21422473 NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_provenance.
- NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_assertion wasDerivedFrom befree-20140225 NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_provenance.
- NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_assertion wasGeneratedBy ECO_0000203 NP337062.RA1ZNOrillPh2LVXAyuQJf1mHyloksRH-4DGrnFq-y8kk130_provenance.